AMPA receptor
AMPA Receptor[edit]
The AMPA receptor is a type of ionotropic glutamate receptor that is critical for fast synaptic transmission in the central nervous system. Named after its selective agonist, _-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), this receptor plays a key role in synaptic plasticity, which is essential for learning and memory.
Structure[edit]
AMPA receptors are tetrameric complexes composed of four subunits, which can be any combination of the GluA1, GluA2, GluA3, and GluA4 subunits. Each subunit consists of an extracellular N-terminal domain, a ligand-binding domain, a transmembrane domain, and an intracellular C-terminal domain. The arrangement of these subunits determines the receptor's properties, such as ion permeability and kinetics.
Function[edit]
AMPA receptors mediate fast excitatory synaptic transmission by allowing the flow of sodium (Na_) and, to a lesser extent, calcium (Ca__) ions across the cell membrane upon activation by the neurotransmitter glutamate. The influx of these ions leads to depolarization of the postsynaptic neuron, which can trigger an action potential if the depolarization is sufficient.
Role in Synaptic Plasticity[edit]
AMPA receptors are crucial for long-term potentiation (LTP) and long-term depression (LTD), two processes that underlie synaptic plasticity. During LTP, the number of AMPA receptors at the synapse increases, enhancing synaptic strength. Conversely, during LTD, the number of receptors decreases, weakening synaptic connections.
Regulation[edit]
The function and trafficking of AMPA receptors are tightly regulated by various mechanisms, including phosphorylation, palmitoylation, and interactions with auxiliary proteins such as TARPs (transmembrane AMPA receptor regulatory proteins). These regulatory processes are essential for maintaining synaptic homeostasis and adapting to changes in synaptic activity.
Clinical Significance[edit]
Dysfunction of AMPA receptors is implicated in several neurological disorders, including epilepsy, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Modulating AMPA receptor activity is a potential therapeutic strategy for these conditions.
Research and Development[edit]
Ongoing research aims to develop drugs that can selectively target AMPA receptors to treat neurological disorders. These include AMPA receptor antagonists and positive allosteric modulators, which can fine-tune receptor activity without directly competing with glutamate.
Related pages[edit]
AMPA receptor[edit]
-
AMPA receptor -
Regulation of AMPAR trafficking
-
AMPA receptor endocytosis
-
L-glutamic acid skeletal
-
AMPA
-
Perampanel structure
